Davis Polk advised the underwriters in connection with an SEC-registered offering by AbbVie Inc. of €1.4 billion aggregate principal amount of senior notes in two series, consisting of €750…
Davis Polk advised the underwriters in connection with the $648 million initial public offering by Datadog, Inc. of 24,000,000 shares of its Class A common stock. The Class A common stock…
Davis Polk advised the underwriter in connection with the SEC-registered offering by PTC Therapeutics, Inc. of 2,475,248 shares of its common stock and the initial purchaser in a concurrent…
Davis Polk advised the joint book-running managers in connection with the $162.4 million SEC-registered follow-on offering of 2,680,089 shares of Class A common stock of Hamilton Lane…
Davis Polk advised IHS Markit Ltd. in connection with its SEC-registered offering of an additional $350 million aggregate principal amount of its 4.250% senior notes due 2029. The…
Davis Polk advised the joint book-running managers in connection with the SEC-registered offering by Deciphera Pharmaceuticals, Inc. of 10,810,810 shares of common stock for gross proceeds…
Davis Polk advised Freeport-McMoRan Inc. (“FCX”) in connection with its SEC-registered offering of $1.2 billion of senior notes. The offering consisted of two tranches of senior notes,…
Davis Polk advised the sole bookrunner in connection with the $168 million SEC-registered secondary offering of 12,000,000 shares of Class A common stock of Hostess Brands, Inc. by certain…
Davis Polk advised the underwriters in connection with the SEC-registered offering of 5,750,000 shares of common stock of Stemline Therapeutics, Inc. for total gross proceeds of…
Davis Polk advised the sole book-running manager and representative of the underwriters in connection with the $70 million follow-on offering of 741,750 shares of common stock of Kinsale…